RITUXAN (rituximab) injection is used for the treatment of patients with large B-cell lymphoma.

RITUXAN (rituximab) is a CD20-directed cytolytic antibody indicated for the treatment of adult patients with:  Non-Hodgkin’s Lymphoma (NHL)  Chronic Lymphocytic Leukemia (CLL)  Rheumatoid Arthritis (RA)  Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA)  Moderate to severe Pemphigus Vulgaris (PV).

RITUXAN (rituximab) injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of RITUXAN (rituximab) injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the RITUXAN (rituximab) injection medicine cost price in India.

The order for RITUXAN (rituximab) injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein-Barr virus-positive mucocutaneous ulcers. It is given by slow injection into a vein.

RITUXAN® (rituximab) injection, for intravenous use Initial U.S. Approval: 1997

Generic Name: rituximab

Injection: 100 mg/10 mL (10 mg/mL) and 500 mg/50 mL (10 mg/mL) solution in single-dose vials

RITUXAN (rituximab Price in UK Brazil India

GET IN TOUCH
with Indian Pharma Network

Indian Pharma Network, Delhi provides access to RITUXAN (rituximab) on the Named Patient Import basis in India.

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient, providing solutions on how to get access of anti cancer medicines which is not available in India.

BRANCH OFFICE : NEW DELHI | BENGALURU | KOLKATA | LUCKNOW | JODHPUR

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

RITUXAN (rituximab) injection suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand RITUXAN (rituximab) injection on prescription and Import License in Patient's Name only.

For overseas patients, RITUXAN (rituximab) injection can be made available in Send your enquiry to find RITUXAN (rituximab) injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for RITUXAN (rituximab) injection.

For RITUXAN (rituximab) injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

FDA Approves First-Ever Treatment for Pediatric GPA, MPA For More Details

FDA approves first treatment for children with rare diseases that cause inflammation of small blood vessels For More Details